SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Sangamo Therapeutics Q1 EPS $(0.370) Misses $(0.290) Estimate, Sales $13.076M Miss $22.740M Estimate

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.370) per share which missed the analyst consensus estimate of $(0.290) by 27.59 percent. This is a 9.76 percent increase over losses of $(0.410) per

Benzinga · 05/11/2020 20:03

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.370) per share which missed the analyst consensus estimate of $(0.290) by 27.59 percent. This is a 9.76 percent increase over losses of $(0.410) per share from the same period last year. The company reported quarterly sales of $13.076 million which missed the analyst consensus estimate of $22.740 million by 42.50 percent. This is a 62.01 percent increase over sales of $8.071 million the same period last year.